SPY316.18+2.40 0.76%
DIA260.72+1.68 0.65%
IXIC10,492.50+148.61 1.44%

Oppenheimer Downgrades Sunesis Pharmaceuticals to Perform

Oppenheimer downgrades Sunesis Pharmaceuticals (NASDAQ:SNSS) from Outperform to Perform.

Benzinga · -
Oppenheimer downgrades Sunesis Pharmaceuticals (NASDAQ: SNSS) from Outperform to Perform.